Concepedia

Yngve Hallström

YH

Statistics

Publications

9

Citations

1.4K

H-Index

9

Active since

2006

Affiliations

Charité - Universitätsmedizin Berlin(Current)

Amgen (United States)

Innsbruck Medical University

Saint Göran Hospital

Universität Innsbruck

Yngve Hallström is an author at Charité - Universitätsmedizin Berlin specializing in pharmacology, pharmacotherapy, and clinical pharmacology.

Publications per year

2006–2021

9

Publications

9

A Controlled Trial of Erenumab for Episodic Migraine

Peter J. Goadsby, Uwe Reuter, Yngve Hallström et al. · New England Journal of Medicine · 2017 · 948 citations · Full text

, , +15

Efficacy of pramipexole in restless legs syndrome: A six‐week, multicenter, randomized, double‐blind study (effect‐RLS study)

Wolfgang H. Oertel, Karin Stiasny‐Kolster, Bettina Bergtholdt et al. · Movement Disorders · 2006 · 130 citations

, , +8

KOMET: an unblinded, randomised, two parallel-group, stratified trial comparing the effectiveness of levetiracetam with controlled-release carbamazepine and extended-release sodium valproate as monotherapy in patients with newly diagnosed epilepsy

Eugen Trinka, Anthony G Marson, Wim Van Paesschen et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 122 citations

, , +14

Migraine-related disability, impact, and health-related quality of life among patients with episodic migraine receiving preventive treatment with erenumab

Dawn C. Buse, Richard B. Lipton, Yngve Hallström et al. · Cephalalgia · 2018 · 91 citations

, , +15

One-year sustained efficacy of erenumab in episodic migraine

Peter J. Goadsby, Uwe Reuter, Yngve Hallström et al. · Neurology · 2020 · 64 citations · Full text

, , +14

1–5 of 9